Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.

Published in: Journal of dual diagnosis (2024)

, 2017, prior to participants enrollment.

Keyphrases